BioReference Laboratories Opko Health Q1 Revenues More Than Double Due to COVID-19 Test Demand The company reported revenues of $545.2 million compared to $211.5 million in the year-ago quarter, primarily driven by COVID-19 testing. BioReference Labs Inks Deal to Provide Rapid PCR, Point-of-Care COVID-19 Testing for MLB The firm is using Mesa Biotech's Accula system for the testing, beginning Thursday, the start of the 2021 MLB season. Opko Health Q4 Revenues More Than Double Thanks to COVID-19 Testing The company's service revenues increased 157 percent to $457.9 million due to significant COVID-19 testing volumes, slightly offset by lower base business volumes. How Will Labs Use Expanded Molecular Testing Capacities Post-COVID-19? Premium While SARS-CoV-2 test demand will likely remain strong well into 2021, the question of what to do with the built-up capacity in a post-COVID-19 environment looms. Opko Health Q3 Revenues Up 87 Percent The firm's subsidiary BioReference Laboratories performed 3.5 million COVID-19 PCR tests and 300,000 serology tests during the quarter. Aug 12, 2020 GeneDx Inks Neonatal Genomic Services Deal With Pediatrix Medical Group Mar 14, 2020 Trump Administration Highlights Role of Private Sector in Effort to Increase Coronavirus Testing Mar 13, 2020 BioReference Partners With NY State to Provide Drive-Through SARS-CoV-2 Testing Mar 5, 2020 Commercial Labs Step up Coronavirus Test Efforts After FDA Guidance Dec 6, 2019 Local Coverage Determinations Roundup: Transplant Genomics, Opko Health Apr 3, 2019 NIPT Laboratories Don't Follow All ACMG Recommendations for Reporting, Patient Education Aug 28, 2018 BioReference Labs' GenPath to Participate in NCI-MATCH Jun 22, 2018 Some Stakeholders Not on Board With Draft Bill on New Dx Regulatory Framework Premium Jan 12, 2018 GeneDx, Radboud UMC Collaborate on Research Into Neurodevelopmental Disorders Nov 22, 2017 Longstanding Genetic Testing Website GeneTests Closing Sep 19, 2017 BioReference, The Garage Form Alliance to Advance Patient Care Jun 7, 2017 UC Health to Have Expanded Access to GeneDx Tests Apr 24, 2017 Diaceutics Inks Deal for BioReference Labs Dx Data Jan 10, 2017 Natera Terminates Bio-Reference Labs NIPT Distribution Agreement Jan 4, 2017 Genetic Testing Firms Establish NIPT Advocacy Organization Jan 4, 2017 Natera Files Suit Against Bio-Reference Laboratories for Breach of Contract Nov 7, 2016 Opko Q3 Revenues Up 108 Percent on Strength of BioReference Sales Oct 11, 2016 Integrating Molecular Tests With EMRs Seen as Essential to Advancing Precision Diagnostics Premium Oct 10, 2016 GeneDx Launches Prenatal Exome Sequencing Test, Plans to Expand Into New Dx Areas Premium May 9, 2016 Opko Q1 Revenues Up Nearly Ninefold Load More Breaking News Enzo Biochem, CLX Health Partner to Support COVID-19 Testing for International Travel Type 1 Diabetes GWAS, Fine-Mapping Leads to New Genetic Loci, Potential Drug Targets LSU Health Sciences Center Wins $2.4M to Lead SARS-CoV-2 Variant Sequencing Program NanoString Technologies, Parker Institute for Cancer Immunotherapy Partner on Cell Therapy Project BGI Americas Collaborating With Champions Oncology on Proteomic Cancer Research Personal Genome Diagnostics Inks Cancer Genomic Profiling Deal with Duke University Health System The Scan Missed Early Cases A retrospective analysis of blood samples suggests early SARS-CoV-2 infections may have been missed in the US, the New York Times reports. Limited Journal Editor Diversity A survey finds low diversity among scientific and medical journal editors, according to The Scientist. How Much of a Threat? Science writes that need for a provision aimed at shoring up genomic data security within a new US bill is being questioned. PNAS Papers on Historic Helicobacter Spread, Brain Development, C. difficile RNAs In PNAS this week: Helicobacter genetic diversity gives insight into human migrations, gene expression patterns of brain development, and more.